Molecules 2008, 13(11), 2758-2785; doi:10.3390/molecules13112758
Article

Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis

email, email and * email
Received: 4 September 2008; in revised form: 13 October 2008 / Accepted: 29 October 2008 / Published: 6 November 2008
(This article belongs to the collection Prodrugs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Polyanionic macromolecules are extremely abundant both in the extracellular environment and inside the cell, where they are readily accessible to many proteins for interactions that play a variety of biological roles. Among polyanions, heparin, heparan sulfate proteoglycans (HSPGs) and glycosphingolipids (GSLs) are widely distributed in biological fluids, at the cell membrane and inside the cell, where they are implicated in several physiological and/or pathological processes such as infectious diseases, angiogenesis and tumor growth. At a molecular level, these processes are mainly mediated by microbial proteins, cytokines and receptors that exert their functions by binding to HSPGs and/or GSLs, suggesting the possibility to use polyanionic antagonists as efficient drugs for the treatment of infectious diseases and cancer. Polysulfated (PS) or polysulfonated (PSN) compounds are a heterogeneous group of natural, semi-synthetic or synthetic molecules whose prototypes are heparin and suramin. Different structural features confer to PS/PSN compounds the capacity to bind and inhibit the biological activities of those same heparin-binding proteins implicated in infectious diseases and cancer. In this review we will discuss the state of the art and the possible future development of polyanionic drugs in the treatment of infectious diseases and cancer.
Keywords: Angiogenesis; Cancer; Infectious diseases; Polyanionics
PDF Full-text Download PDF Full-Text [215 KB, uploaded 18 June 2014 19:28 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Urbinati, C.; Chiodelli, P.; Rusnati, M. Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis. Molecules 2008, 13, 2758-2785.

AMA Style

Urbinati C, Chiodelli P, Rusnati M. Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis. Molecules. 2008; 13(11):2758-2785.

Chicago/Turabian Style

Urbinati, Chiara; Chiodelli, Paola; Rusnati, Marco. 2008. "Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis." Molecules 13, no. 11: 2758-2785.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert